8888888888888
SENIOR MEMBER
![](/styles/default/xenforo/ranks/Major.jpg)
- Joined
- Nov 29, 2016
- Messages
- 2,371
- Reaction score
- 0
- Country
- Location
A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer PFE, +1.16% and Moderna MRNA, -0.10% vaccines as they are for the AstraZeneca AZN, +1.99% vaccine that was produced with the university's help. According to the study, 4 in 1 million people experience cerebral venous thrombosis after getting the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 -- 39 in a million patients -- than it is for those for get vaccinated. AstraZeneca's vaccine use has been halted or limited in many countries on blood clot concerns.
www.marketwatch.com
![www.marketwatch.com](/proxy.php?image=https%3A%2F%2Fs.wsj.net%2Fpublic%2Fresources%2FMWimages%2FMW-GP644_MicroS_ZG_20180906154215.jpg&hash=ed81f5133590f0cd8700100d1b3cc3d8&return_error=1)
Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study
A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for...
![www.marketwatch.com](/proxy.php?image=https%3A%2F%2Fmw4.wsj.net%2Fmw5%2Fcontent%2Fimages%2Ffavicons%2Fapple-touch-icon.png&hash=c08099272886753aad4e1ea039bd96a9&return_error=1)